8-K: Acadia Healthcare Q1 2026 Results: Guidance Raised

Acadia Healthcare announced first quarter 2026 results, with revenue up 7.6% year-over-year, and raised full-year guidance for Adjusted EBITDA and Adjusted EPS.

Summary

• Acadia Healthcare reported first quarter 2026 revenue of $828.8 million, an increase of 7.6% compared to the first quarter of 2025.
• Same-facility revenue grew by 7.3%, driven by a 5.6% increase in revenue per patient day and a 1.6% increase in patient days.
• Net income attributable to Acadia was $0.05 per diluted share, down from $0.09 in the prior year.
• Adjusted net income was $33.3 million, or $0.37 per diluted share, compared to $36.9 million, or $0.40 per diluted share, in Q1 2025.
• Adjusted EBITDA increased by 7% to $144.2 million, exceeding guidance.
• The company added 82 newly licensed beds during the quarter.
• Acadia is increasing its full-year 2026 guidance for Adjusted EBITDA and Adjusted EPS.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive report, with revenue growth exceeding expectations and full-year guidance being raised, despite a dip in net income per share.

Positives

• Revenue increased by 7.6% to $828.8 million in Q1 2026 compared to Q1 2025.
• Same-facility revenue grew by 7.3%, indicating strong performance in existing operations.
• Revenue per patient day increased by 5.6%, suggesting improved pricing or service mix.
• Patient days increased by 1.6%, showing higher utilization.
• Adjusted EBITDA rose by 7% to $144.2 million, surpassing expectations.
• 82 new beds were added, expanding capacity for future growth.
• Full-year 2026 guidance for Adjusted EBITDA and Adjusted EPS has been increased.

Negatives

• Net income attributable to Acadia decreased to $0.05 per diluted share from $0.09 in the prior year.
• Adjusted net income attributable to Acadia decreased to $0.37 per diluted share from $0.40 in the prior year.
• Specialty treatment facility revenue decreased by 6.5% due to facility closures.
• Operating expenses increased by 7.6%, matching the revenue growth rate.
• Interest expense increased significantly from $29 million to $38 million due to higher borrowings.

Risks

• Potential difficulties in integrating acquired facilities or realizing expected synergies.
• Ability to add beds, expand services, and improve efficiencies.
• Potential reductions in payments from government and commercial payors, especially due to the 'One Big Beautiful Bill Act' (OBBBA).
• Occurrence of patient incidents, governmental investigations, litigation, and adverse regulatory actions.
• Risk of not generating sufficient cash from operations to service debt and meet capital requirements.
• Changes in expectations from actuarial reviews of liability reserves.
• Potential disruptions to IT systems or cybersecurity incidents.
• Operating difficulties including economic disruption, reduced admissions due to OBBBA requirements, increased labor and supply chain costs, and competitive changes.

Future Outlook

Acadia has increased its full-year 2026 guidance for Adjusted EBITDA to a range of $580 million to $615 million (from $575 million to $610 million) and for Adjusted earnings per diluted share to $1.35 to $1.60 (from $1.30 to $1.55). The company also provided Q2 2026 guidance, expecting revenue between $835 million and $850 million and Adjusted EBITDA between $142 million and $152 million.

Management Comments

• "The good start to the year reflects disciplined execution throughout Acadia as we provide quality care for individuals seeking treatment for mental health and substance abuse issues."
• "Strong patient volumes across our Acute and RTC businesses, along with continued operating efficiencies across the Company, enabled us to exceed the high end of our Adjusted EBITDA guidance."
• "I am very pleased with how the team has responded in my first few months back as CEO, and we are building on this progress with a clear focus on sustained performance and longterm value."

Industry Context

StockSavvy.ai notes that Acadia Healthcare's Q1 2026 results, particularly the increase in revenue per patient day and the expansion of bed capacity, align with broader trends in the behavioral healthcare sector, which is experiencing sustained demand for services. The company's ability to raise guidance suggests effective operational management and pricing power within this growing market.

Comparison to Industry Standards

• Acadia's same-facility revenue growth of 7.3% in Q1 2026 is robust compared to the typical low-to-mid single-digit organic growth seen in many healthcare sub-sectors.
• The increase in revenue per patient day of 5.6% indicates strong pricing power, which is a key differentiator in the competitive behavioral health landscape.
• The company's Adjusted EBITDA margin, while not explicitly stated for comparison, is generally a key metric for evaluating operational efficiency against peers like Universal Health Services (UHS) or HCA Healthcare, though direct comparison is difficult due to differing service lines and reporting structures.

Legal Proceedings

• Costs related to government investigations were $12.4 million in Q1 2026.
• Legal settlements expense of $13.75 million in Q1 2026 related to the Sandoval v. Acadia Healthcare Company, Inc. case.

Stakeholder Impact

• Shareholders: Potential for increased value due to raised full-year guidance and positive revenue trends, offset by lower net income per share.
• Employees: Increased salaries, wages, and benefits due to new facility openings and routine annual increases.
• Patients: Continued access to behavioral healthcare services with expanded bed capacity.
• Government Payors: Potential impact from changes in Medicaid financing mechanisms due to the OBBBA.
• Creditors: Increased interest expense due to higher borrowings, but leverage ratio remains within manageable levels.

Next Steps

• Conduct conference call on April 30, 2026, to discuss Q1 2026 financial results.
• Continue to add beds and expand services at existing and new facilities.
• Monitor impact of the 'One Big Beautiful Bill Act' (OBBBA) on government payor reimbursements.
• Manage operating expenses, including labor and supply chain costs.

Key Dates

Recommendation

While the company raised its full-year guidance and showed strong revenue growth, the decrease in net income per share and the significant increase in interest expense warrant a cautious approach. The company is navigating complex regulatory changes and operational challenges, making a 'hold' recommendation appropriate until further clarity on sustained profitability and debt management emerges.

Keywords

Acadia Healthcare, Behavioral Healthcare, Q1 2026 Results, Adjusted EBITDA, Revenue Growth, Patient Days, Guidance Increase, Mental Health Services